Status:
TERMINATED
Pulmonary Rehabilitation in End-Stage Liver Disease
Lead Sponsor:
Mayo Clinic
Conditions:
End Stage Liver Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to assess the impact of exercise on sarcopenia and frailty. The exercise that will be performed in this study will include either pulmonary rehabilitation or a formal home...
Detailed Description
Participants will be randomized into two groups. The Pulmonary Rehabilitation group will undergo exercise under a supervised setting for a total duration of 12 weeks. Patients will perform endurance (...
Eligibility Criteria
Inclusion
- wait listed for liver transplantation with poor 6 MWT
Exclusion
- age \< 18 years
- recent hospitalization (within 14 days) due to decompensation, variceal bleeding in the previous 1 month
- large esophageal varices without primary prophylaxis
- active excessive alcohol intake (in the previous 3 months)
- current overt uncontrolled hepatic encephalopathy
- hepatopulmonary syndrome with uncontrolled hypoxia
- portopulmonary hypertension
- inability to perform exercise
- marked symptomatic comorbidities (cardiac, pulmonary, renal).
Key Trial Info
Start Date :
February 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 9 2024
Estimated Enrollment :
4 Patients enrolled
Trial Details
Trial ID
NCT03266575
Start Date
February 1 2018
End Date
December 9 2024
Last Update
December 12 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905